Mereo BioPharma Group plc (MREO:NASDAQ) closed at $0.292 on October 27, 2026, up 6.07% on the day. The stock trades 87.7% below its 52-week high of $2.37 and 45.9% above its 52-week low of $0.200. Over the past year, it lost 86.3%. Mereo BioPharma Group plc is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since October 27, 2025, MREO closed higher on 103 days (41%). Its best day was December 30, 2025 (+30.18%) and its worst was December 29, 2025 (-87.66%). The stock moved 10% or more in a single session 23 times. It opened at least 5% above the previous day's high 5 times.
Mereo BioPharma Group PLC was incorporated and registered in England and Wales under the name Mereo BioPharma Group Limited on March 10, 2015. On June 3, 2016, the Company re-registered as a public company and changed its name to Mereo BioPharma Group PLC. The Company is a speciality biopharmaceutical company. The Company is principally engaged in the research and development of novel pharmaceuticals.
Find more stocks like MREO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.